https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg 0 0 2021-07-04 / Cancer Immunol Immunother 2021 Jul; https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg 2021-07-04 / Cancer Immunol Immunother 2021 Jul;2021-07-04 00:00:002021-08-02 06:57:43Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Long-term follow up of patients with mesothelioma treated with dendritic cell therapy in three phase I trials.
- Phase 1 trial of autologous dendritic cell vaccination with imiquimod immunomodulation in children and adults with refractory sarcoma.
- Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma